Lanean...
Bruton's tyrosine kinase is a potential therapeutic target in prostate cancer
Bruton's tyrosine kinase (BTK) is a non-receptor tyrosine kinase that has mainly been studied in haematopoietic cells. We have investigated whether BTK is a potential therapeutic target in prostate cancer. We find that BTK is expressed in prostate cells, with the alternate BTK-C isoform predomi...
Gorde:
| Argitaratua izan da: | Cancer Biol Ther |
|---|---|
| Egile Nagusiak: | , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Taylor & Francis
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4846115/ https://ncbi.nlm.nih.gov/pubmed/26383180 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2015.1078023 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|